Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib


Creative Commons License

Kus T., Aktas G., Sevinc A., KALENDER M. E., YILMAZ M., KUL S., ...More

ONCOTARGETS AND THERAPY, vol.8, pp.3749-3756, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 8
  • Publication Date: 2015
  • Doi Number: 10.2147/ott.s94945
  • Journal Name: ONCOTARGETS AND THERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.3749-3756
  • Keywords: lung adenocarcinoma, erlotinib, F-18-fluorodeoxyglucose positron emission tomography/computed tomography, maximum standardized uptake value, treatment response, prognosis, PLATINUM-BASED CHEMOTHERAPY, OPEN-LABEL, PHASE-III, 2ND-LINE TREATMENT, SMOKING HISTORY, SUPPORTIVE CARE, EGFR MUTATIONS, CANCER, GEFITINIB, MULTICENTER
  • Akdeniz University Affiliated: Yes

Abstract

Purpose: To investigate whether the initial maximum standardized uptake value (SUVmax) on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) has a prognostic significance in metastatic lung adenocarcinoma.